$58.95 million in sales expected for Oaktree Specialty Lending Co. (NASDAQ:OCSL) this quarter

Wall Street analysts expect Oaktree Specialty Lending Co. (NASDAQ:OCSL – Get a rating) to post sales of $58.95 million for the current fiscal quarter, according to Zacks. Two analysts have made earnings estimates for Oaktree Specialty Lending. The highest sales estimate is $60.36 million and the lowest is $57.54 million. Oaktree Specialty Lending posted sales of $41.94 million in the same quarter last year, suggesting a positive growth rate of 40.6% year over year. The company is due to release its next results on Monday, January 1.

On average, analysts expect Oaktree Specialty Lending to record annual sales of $243.45 million for the current year, with estimates ranging from $239.32 million to $247.59 million. dollars. For the next fiscal year, analysts expect the company to record sales of $247.36 million, with estimates ranging from $240.62 million to $254.10 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts who cover Oaktree’s specialty lending.

Oaktree Specialty Lending (NASDAQ:OCSL – Get a rating) last released its quarterly results on Thursday, February 3. The credit service provider reported EPS of $0.17 for the quarter, beating the consensus estimate of $0.16 by $0.01. The company posted revenue of $64.94 million in the quarter, versus analyst estimates of $57.51 million. Oaktree Specialty Lending had a return on equity of 8.82% and a net margin of 89.41%. During the same period last year, the company posted earnings per share of $0.14.

(A d)

This title could be the most promising in the biotech sector and at a great price.

Innovation doesn’t happen every day, but when it does, in this industry, it can literally change people’s lives forever.

Today we spotlight a stock poised to change the game of biotech.

Step into innovation with our special report today.

Separately, Zacks Investment Research upgraded shares of Oaktree Specialty Lending from a “hold” rating to a “buy” rating and set a price target of $8.50 for the company in a Wednesday, Feb. 9 research report.

Shares of Oaktree Specialty Lending opened at $7.34 on Friday. Oaktree Specialty Lending has a 1-year low of $6.11 and a 1-year high of $7.81. The stock has a market capitalization of $1.32 billion, a PE ratio of 5.73, a P/E/G ratio of 0.89 and a beta of 1.39. The company has a debt ratio of 0.48, a current ratio of 0.13 and a quick ratio of 0.13. The stock’s fifty-day moving average is $7.44 and its two-hundred-day moving average is $7.39.

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 31. Shareholders of record on Tuesday, March 15 will receive a dividend of $0.16. This represents an annualized dividend of $0.64 and a dividend yield of 8.72%. The ex-dividend date is Monday, March 14. This is a boost from Oaktree Specialty Lending’s previous quarterly dividend of $0.16. Oaktree Specialty Lending’s dividend payout ratio (DPR) is 50.00%.

In related news, majority shareholder Leonard M. Tannenbaum sold 200,000 shares of the company in a transaction dated Monday, December 27. The shares were sold at an average price of $7.54, for a total value of $1,508,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, accessible via this hyperlink. Insiders own 0.32% of the shares of the company.

A number of institutional investors have recently increased or reduced their stake in the company. Ares Management LLC increased its stake in shares of Oaktree Specialty Lending by 7.7% during the 4th quarter. Ares Management LLC now owns 5,490,077 shares of the credit service provider worth $40,956,000 after purchasing an additional 393,658 shares during the period. Bruni JV & Co. Co. increased its holdings in Oaktree Specialty Lending by 0.5% during the fourth quarter. Bruni JV & Co. Co. now owns 4,514,890 shares of the credit service provider worth $33,681,000 after purchasing an additional 20,900 shares last quarter. Oaktree Capital Management LP increased its position in Oaktree Specialty Lending by 1,526.9% during the third quarter. Oaktree Capital Management LP now owns 4,490,368 shares of the credit service provider worth $31,701,000 after purchasing an additional 4,214,368 shares during the period. Millennium Management LLC increased its stake in Oaktree Specialty Lending by 27.2% in the fourth quarter. Millennium Management LLC now owns 2,875,374 shares of the credit service provider valued at $21,450,000 after purchasing an additional 614,908 shares last quarter. Finally, CLARET ASSET MANAGEMENT Corp increased its position in Oaktree Specialty Lending shares by 16.1% during the 3rd quarter. CLARET ASSET MANAGEMENT Corp now owns 2,845,675 shares of the credit services provider valued at $20,090,000 after acquiring an additional 393,827 shares during the period. 63.27% of the shares are held by institutional investors.

About Oaktree Specialty Loans (Get a rating)

Oaktree Specialty Lending Corp. operates as an alternative asset manager that provides financing solutions to growing private small and medium enterprises. While fostering growth is our primary mission, a singular purpose guides all of our activities in Partnering for Success.

Read more

Get a Free Copy of Zacks Research Report on Oaktree Specialty Lending (OCSL)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

History and Earnings Estimates for Oaktree Specialty Lending (NASDAQ:OCSL)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Oaktree Specialty Loans right now?

Before you consider Oaktree Specialty Loans, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Oaktree Specialty Lending wasn’t on the list.

Although Oaktree Specialty Lending currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

About Clayton Arredondo

Check Also

Virgin Money UK (LON:VMUK) receives a “Buy” rating from Shore Capital

Virgin Money UK (LON:VMUK – Get a rating)The stock had its “buy” rating restated by …